New vaccine offers fresh hope for controlling whooping cough
Date:
A human challenge trial* has shown a new vaccine could offer better protection against whooping cough.
The new study, delivered in partnership between the University of Southampton, University Hospital Southampton, and the University of Oxford, is the first to show that a vaccine can stop the bacteria that cause whooping cough from living in the nose and throat.
Read the full article here.
*A total of 53 adult volunteers took part in the trial at the NIHR Southampton CRF and in Oxford. Two to four months after receiving either the vaccine or a placebo, participants were exposed to the bacteria in a carefully controlled setting. They then stayed in a quarantine facility for 16 nights, where researchers monitored their health and collected samples.
